The link to share this saved search was copied to your clipboard. Paste it where you want to share.
Share saved search with others
Public share link
LINK
Delete Saved Search Confirmation
search will be permanently removed from Finder.
News Analysis
title
message
Alon Ben-Noon
CEO & Co-Founder at NeuroSense Therapeutics
Edit profile
ABOUT
It is our goal to cure ALS.
NeuroSense Therapeutics is a drug development company working on an effective treatment for ALS patients.
The drug development plan is based on innovative and revolutionary research conducted at the Weizmann Institute of Science.
The concept focuses on miRNAs and is widely supported by leading KOLs worldwide.
NeuroSense Therapeutics is currently preparing for a clinical study in patients.